Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

BeiGene Switzerland GmbH - Standard of Care is Not Enough! Talking Immunotherapy Clinical Trials in GI Cancers

Questions about Trials? Connect With your Expert!

Date

10 Sep 2022

Session

BeiGene Switzerland GmbH - Standard of Care is Not Enough! Talking Immunotherapy Clinical Trials in GI Cancers

Topics

Patient Education and Advocacy;  Clinical Research;  Cancer Biology;  Communication Skills;  Tumour Immunology;  Molecular Oncology;  Immunotherapy

Tumour Site

Oesophageal Cancer;  Gastric Cancer;  Hepatobiliary Cancers;  Colon and Rectal Cancer;  Gastro-Oesophageal Junction Cancer

Presenters

Stefano Cascinu

Authors

E. Smyth1, E. Van Cutsem2, M.P. Ducreux3, S. Lorenzen4, S. Cascinu5

Author affiliations

  • 1 Gastrointestinal Oncology Department, Addenbrooke's Hospital, CB2 0QQ - Cambridge/GB
  • 2 Digestive Oncology Department, UZ Leuven - University Hospitals Leuven - Campus Gasthuisberg, 3000 - Leuven/BE
  • 3 Medical Oncology Department, Gustave Roussy - Cancer Campus, 94805 - Villejuif/FR
  • 4 Hematology And Oncology Dept., Klinikum Rechts der Isar - Technische Universitaet Muenchen, 81675 - Munich/DE
  • 5 Oncology Dept., Azienda Ospedaliero - Universitaria Policlinico di Modena, 41125 - Modena/IT

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.